Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.
Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J, Gringeri A, Joao-Diniz M, Lopaciuk S, Negrier C, Quintana M, Tagariello G, Tjonnfjord GE, Villar VA, Vorlova Z. Rodriguez-Merchan EC, et al. Among authors: gringeri a. Haemophilia. 2004 Sep;10 Suppl 2:50-2. doi: 10.1111/j.1365-2516.2004.00941.x. Haemophilia. 2004. PMID: 15385047
Special lectures in haemophilia management.
Batorova A, High KA, Gringeri A. Batorova A, et al. Among authors: gringeri a. Haemophilia. 2010 Jul;16 Suppl 5:22-8. doi: 10.1111/j.1365-2516.2010.02289.x. Haemophilia. 2010. PMID: 20590852 Review.
Major challenges of intensive treatment regimens employed today, such a short half life of haemophilia therapeutics with a need for frequent injections and the risk of inhibitor, encourage further development towards the production of factor concentrates with prolon …
Major challenges of intensive treatment regimens employed today, such a short half life of haemophilia therapeutics with a nee …
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp E, Astermark J, Björkman S, Blanchette VS, Fischer K, Giangrande PL, Gringeri A, Ljung RC, Manco-Johnson MJ, Morfini M, Kilcoyne RF, Petrini P, Rodriguez-Merchan EC, Schramm W, Shapiro A, van den Berg HM, Hart C. Berntorp E, et al. Among authors: gringeri a. Haemophilia. 2003 May;9 Suppl 1:1-4. doi: 10.1046/j.1365-2516.9.s1.17.x. Haemophilia. 2003. PMID: 12709030
The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report.
Valentino LA, Carcao M, Mathew P, Leissinger CA, Berntorp E, Blanchette V, Escuriola-Ettingshausen C, Ewenstein B, Ewing N, Gringeri A, Hoots WK, Negrier C. Valentino LA, et al. Among authors: gringeri a. Haemophilia. 2009 Jul;15(4):959-65. doi: 10.1111/j.1365-2516.2008.01953.x. Epub 2009 Mar 23. Haemophilia. 2009. PMID: 19320750 No abstract available.
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Astermark J, Altisent C, Batorova A, Diniz MJ, Gringeri A, Holme PA, Karafoulidou A, Lopez-Fernández MF, Reipert BM, Rocino A, Schiavoni M, von Depka M, Windyga J, Fijnvandraat K; European Haemophilia Therapy Standardisation Board. Astermark J, et al. Among authors: gringeri a. Haemophilia. 2010 Sep 1;16(5):747-66. doi: 10.1111/j.1365-2516.2010.02231.x. Epub 2010 Apr 14. Haemophilia. 2010. PMID: 20398077 Review.
192 results